EUVIMEDEUVIMED entdecken
Crossref

Cross‐Reactivity of SARS ‐ CoV ‐2 Antibodies With Typhoid Flagellar‐H Protein

Aneela Pasha iD, Mohammad Saeed iD

Tropical Medicine & International Health · 2025

DOI: 10.1111/tmi.70027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tropical Medicine & International Health, 2025. Verfasst von Aneela Pasha und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Salmonella typhi, Typhoid Fever. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antigen cross‐reactivity in infections may induce heterologous immunity, leading to immunological protection against widely divergent organisms. We hypothesised that this may be a factor in the varying intensity of COVID‐19 infection globally.

Methods

During the COVID‐19 pandemic, we tested 46 symptomatic patients for both COVID‐19 antibodies and the Typhidot test. The kappa statistic in STATA 16.0 was used to analyse agreement between the two tests. Python‐based k‐mer analysis was used to identify overlapping fragments between SARS‐CoV‐2 and Salmonella typhi proteins. PEP‐Fold3, TM‐align and RasMol software were used to evaluate the 3D‐structural changes. World COVID‐19 and Typhoid mortality and infection statistics were obtained from published data. Line graphs were used to assess correlations between Typhoid cases and COVID‐19 mortality.

Results

There was a high degree of agreement between Typhidot and COVID‐19 antibody tests (Cohen's kappa = 0.43, p = 0.0016). A 5‐amino‐acid peptide, NGVEG, located in the receptor binding motif (RBM) of the SARS‐CoV‐2 Spike protein matched with the Typhoid flagellar‐H protein on k‐mer analysis. SARS‐CoV‐2 Delta (B.1.617.2) variant 3D structure displayed marked changes that may have altered this cross‐reactivity. COVID‐19 mortality between Pre‐Delta (2020) and Post‐Delta (2021) periods showed a negative correlation in Typhoid endemic regions and a reverse trend in non‐endemic regions.

Conclusion

Cross‐reactivity of Typhoid flagellar‐H protein antibodies with SARS‐CoV‐2, mediated by a peptide in the RBM, may have provided partial heterologous immunity to COVID‐19 in Typhoid endemic regions and this was eliminated by the Delta variant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Salmonella typhiTyphoid FeverAntibodies, ViralAntibodies, BacterialAntigens, BacterialFlagellinHumansCross ReactionsFemaleMaleAdultMiddle Aged

Stichwörter der Autor:innen

COVID‐19SARS‐CoV‐2cross‐reactivityheterologous immunitytyphoid

Substanzen

Antibodies, ViralAntibodies, BacterialAntigens, BacterialFlagellin

Autor:innen und Institutionen

  • Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
  • ImmunoCure - Center for Inflammatory Diseases, Karachi, Pakistan.

ORCID-Profile: Aneela Pasha, Mohammad Saeed

Zitieren

APA

Pasha, A., & Saeed, M. (2025). Cross‐Reactivity of SARS ‐ CoV ‐2 Antibodies With Typhoid Flagellar‐H Protein. Tropical Medicine & International Health. https://doi.org/10.1111/tmi.70027

Vancouver

Pasha A, Saeed M. Cross‐Reactivity of SARS ‐ CoV ‐2 Antibodies With Typhoid Flagellar‐H Protein. Tropical Medicine & International Health. 2025. doi:10.1111/tmi.70027

BibTeX
@article{Pasha2025,
  author = {Pasha, Aneela and Saeed, Mohammad},
  title = {Cross‐Reactivity of SARS ‐ CoV ‐2 Antibodies With Typhoid Flagellar‐H Protein},
  journal = {Tropical Medicine & International Health},
  year = {2025},
  doi = {10.1111/tmi.70027}
}
Kostenlos starten →